Peter Libby

Brigham and Women's Hospital — United States

Immunology and Microbiology · Life Sciences

25h-index6.9kcitations92works1.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atherosclerosis and Cardiovascular Diseases(20), Lipoproteins and Cardiovascular Health(14), Protease and Inhibitor Mechanisms(6), Eicosanoids and Hypertension Pharmacology(6), Coronary Interventions and Diagnostics(5)

Publications91 total

Clonal Hematopoiesis and Incident Heart Failure
JAMA Cardiology·2025· 2 citedOpen Access
Abstract 4366096: Eicosapentaenoic Acid Attenuates Oxidation of Lp(a) and other Atherogenic Lipoproteins by a Potential Scavenging Mechanism
Circulation·2025
Abstract 4368948: Eicosapentaenoic Acid (EPA) Limits Lipoprotein(a) Oxidation and its Related Effects on Endothelial Cell Stress Response Protein Expression
Circulation·2025
Abstract 4366197: Selnoflast reduces markers of systemic inflammation in participants with coronary artery disease and elevated C-reactive protein
Circulation·2025
A new comprehensive parameter combining residual C-reactive protein and neutrophil risk predicting adverse events in Chinese patients after percutaneous coronary intervention: A multi-center prospective cohort study
Chinese Medical Journal·2025Open Access
Abstract 4369050: Eicosapentaenoic Acid (EPA) and GLP-1 Receptor Agonist Combination Enhanced Expression of Src Kinase and Related Pathways in Endothelial Cells during Inflammation
Circulation·2025
Lipoprotein(a)—To test or not to test, not a dilemma but a mandate
Journal of clinical lipidology·2025
Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Thrombosis and Haemostasis·2025· 3 citedOpen Access
Multitargeted Reduction of Inflammation and Atherosclerosis in <i>Tet2</i> -deficient CHIP via XPO1 Inhibition and Atf3 restoration
2025· 1 citedOpen Access
Emerging Pathways of Action of Eicosapentaenoic Acid (EPA)
JACC Basic to Translational Science·2025· 7 citedOpen Access
Abstract 4143830: Clonal hematopoiesis portends worse mortality among individuals with ATTR cardiac amyloidosis
Circulation·2024
Abstract 4125992: Eicosapentaenoic Acid (EPA) Increases Expression of Nrf2-mediated Antioxidant Response Element and Heme Oxygenase-1 in Cytokine-Activated Endothelial Cells
Circulation·2024· 1 cited
Abstract 4143799: Dose-Dependent Inhibition of Lp(a) Oxidation by Eicosapentaenoic Acid (EPA) Compared to a Fibrate and Statin due to Lipid Interactions and Antioxidant Properties
Circulation·2024
Eicosapentaenoic acid increases expression of cytoprotective proteins in the antioxidant response element (ARE) during inflammation in endothelial cells
Atherosclerosis·2024Open Access
Abstract 13140: Eicosapentaenoic Acid (EPA) Restores Pulmonary Endothelial Nitric Oxide Bioavailability Following Exposure to Urban Air Pollution Small Particles
Circulation·2021
Eicosapentaenoic Acid Reverses Endothelial Dysfunction following Exposure to the Cytokine IL-6 in Contrast to Docosahexaenoic and Arachidonic Acids
Journal of clinical lipidology·2021
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability and Changes Fatty Acid Content in a Manner Distinct from Docosahexaenoic Acid
Journal of clinical lipidology·2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
2021· 8 citedOpen Access
980: Eicosapentaenoic Acid Reduces Pulmonary Endothelial Inflammation Caused by Cytokine Treatment
Critical Care Medicine·2020
Abstract 174: Na <sup>+</sup> -H <sup>+</sup> Exchanger 1 Determines Atherosclerotic Lesion Acidification and Promotes Atherogenesis
Arteriosclerosis Thrombosis and Vascular Biology·2019
page 1 of 5Next →

Frequent Co-authors

Galina K. Sukhova(6), Uwe Schönbeck(3), Peter Ganz(3), S.E. Nissen(3), Stephen J. Warner(2), Edi Brogi(2), Robert O. Bonow(2), Douglas P. Zipes(2), Bonow Ro(2), Douglas L. Mann(2), Scott Kinlay(2), Masanori Aikawa(2), Scott J. Swanson(2), Frederick J. Schoen(2), Deepak L. Bhatt(2), Gregory Y.H. Lip(2), Samuel Z. Goldhaber(2), Behnood Bikdeli(2), F. Mach(2), Jean‐Yves Bonnefoy(2)